ArticleTranslational oncology2019

MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report.

Karim Rihawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.